Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Walgreens, the exclusive retailer for Red Nose Day, is once again selling Red Noses at its stores across the U.S. after a two-year hiatus due to COVID-19. The campaign, running until May 31, supports efforts to combat child poverty. Since 2015, Red Nose Day has raised $275 million, with Walgreens contributing over $140 million. Customers can purchase a Red Nose for $1 and donate at checkout. Funds raised support various organizations dedicated to children’s welfare, addressing healthcare, nutrition, and education.
Blue Shield of California and Walgreens Health are launching 12 new Walgreens Health Corner locations in the San Francisco Bay Area and Los Angeles County to enhance access to in-person and virtual healthcare. The services, available at no additional cost to eligible Blue Shield members, include health screenings, medication counseling, and chronic condition management. This partnership aims to improve care management and reduce healthcare gaps in local communities, with plans for eight additional locations later this year. The initiative is part of the Health Reimagined strategy.
Walgreens Boots Alliance (WBA) reported Q2 fiscal 2022 earnings with an EPS of $1.02, down from $1.06 a year ago. However, adjusted EPS rose 25.9% to $1.59. Sales from continuing operations increased 3.0% to $33.8 billion, driven by strong performance in U.S. retail and COVID-19 services. Operating income rose significantly to $1.2 billion, while net earnings were $883 million, down from $922 million year-over-year. The company is progressing with its Boots business review and expects annual savings of $3.3 billion by 2024.
Walgreens Boots Alliance (WBA) and VillageMD are set to launch three new Village Medical at Walgreens primary care practices in Southern New Hampshire by the end of summer 2022. The first location opens on April 19 in Hooksett, with additional sites in Manchester and Nashua. This initiative will create over 80 full-time jobs, including 35 STEM positions. The partnership aims to enhance accessible healthcare for local communities, addressing significant gaps in coverage. WBA plans to expand to over 600 practices nationwide by 2025, reinforcing its commitment to community health.
Tripadvisor has partnered with Walgreens to promote safe travel during spring break, emphasizing COVID-19 testing access for travelers. This initiative targets college students and families, showcasing Walgreens' drive-thru COVID-19 testing and vaccination options. A Tripadvisor survey reveals 45% of Americans plan to travel in March and April, with 68% of Gen Z intending to get tested. As travel demand grows, 62% of Americans prefer businesses with COVID-19 safety measures. This partnership highlights a strategic move to capture digital media advertising amid increasing travel activity.
Walgreens and Labcorp have launched the nationwide availability of the Pixel by Labcorp® COVID-19 at-home collection kit, accessible at no cost to eligible individuals via Labcorp OnDemand™. This initiative, in partnership with the U.S. Department of Health and Human Services, aims to enhance testing accessibility for underserved communities. Walgreens President John Standley emphasized the importance of reducing healthcare barriers, particularly for uninsured populations. The program complements Walgreens' existing free drive-thru testing at over 7,000 locations and contributes to broader healthcare efforts amidst evolving COVID-19 conditions.
The UK’s leading skincare brand, No7, has shown superior hydration results in a recent study compared to pricier competitors in the US. Specifically, its age defying day creams outperform moisturizers costing ten times more. This follows a successful UK sales record, with one cream sold every ten seconds in 2021. The brand's new marketing campaign, "The UK’s Best-Kept Skincare Secret," aims to establish a stronger presence in the US market. Additionally, No7 is launching more sustainable packaging and a consumer-focused challenge to demonstrate product efficacy.
Walgreens Boots Alliance (WBA) will announce its fiscal 2022 Q2 earnings results on March 31, 2022, at 7 a.m. Eastern Time, followed by a management conference call at 8:30 a.m. The call will be accessible via the WBA investor relations website and will be archived for 12 months. WBA operates approximately 13,000 locations across the US, Europe, and Latin America, focusing on integrated healthcare and retail pharmacy services. The company is recognized for its sustainable practices and its commitment to creating healthier communities.
Summary not available.
Walgreens Boots Alliance (Nasdaq: WBA) and VillageMD have announced the opening of five new Village Medical at Walgreens practices in the Jacksonville area. This initiative aims to enhance healthcare accessibility and will create over 295 new jobs, including 100 in STEM fields. The first practice opens on February 15, 2022. This expansion follows recent openings in Orlando and Tampa, solidifying their presence in the Florida market.